首页 > 最新文献

Journal of Clinical Neuroscience最新文献

英文 中文
Evaluating single-level vs. multi-level lateral lumbar interbody fusion: Clinical outcomes and complications
IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.jocn.2025.111082
Akihiko Hiyama, Daisuke Sakai, Hiroyuki Katoh, Masato Sato, Masahiko Watanabe

Objective

Lateral Lumbar Interbody Fusion (LLIF) treats lumbar degenerative diseases (LDD) with spinal alignment and decompression advantages but can cause sensory and motor disturbances, especially in multilevel procedures. This study compares single-level and multi-level LLIF focusing on sensory and motor disturbances, surgical duration, and quality of life (QOL).

Methods

A retrospective review of 139 patients (84 males, 55 females; average age 70 years) with LDD who underwent LLIF and posterior fixation between May 2018 and January 2023 was conducted. Patients were divided into two groups: 89 patients who underwent single-level LLIF and 50 patients who underwent multi-level LLIF (two or more levels). Data on demographics, surgical details, perioperative complications, and clinical outcomes, including pain scores (Numeric Rating Scales: NRS) and QOL assessments (Japanese Orthopaedic Association Back Pain Evaluation Questionnaire: JOABPEQ), were collected preoperatively and one year postoperatively. Statistical analysis was performed to compare the outcomes between the two groups.

Results

Patients who underwent multi-level LLIF had significantly longer operative times (145.1 min vs. 98.9 min, p < 0.001) and higher estimated blood loss (126.5 mL vs. 62.9 mL, p < 0.001) compared with the single-level group. Both groups significantly improved pain intensity and QOL, including NRS and JOABPEQ score, with no significant differences in perioperative complication rates (cage subsidence, motor paralysis, thigh pain/numbness) or revision rates (4 % vs. 8 %, p = 0.396).

Conclusions

Short-term clinical outcomes suggested that both single-level and multi-level LLIF effectively improved pain and QOL outcomes in patients with LDD.
{"title":"Evaluating single-level vs. multi-level lateral lumbar interbody fusion: Clinical outcomes and complications","authors":"Akihiko Hiyama,&nbsp;Daisuke Sakai,&nbsp;Hiroyuki Katoh,&nbsp;Masato Sato,&nbsp;Masahiko Watanabe","doi":"10.1016/j.jocn.2025.111082","DOIUrl":"10.1016/j.jocn.2025.111082","url":null,"abstract":"<div><h3>Objective</h3><div>Lateral Lumbar Interbody Fusion (LLIF) treats lumbar degenerative diseases (LDD) with spinal alignment and decompression advantages but can cause sensory and motor disturbances, especially in multilevel procedures. This study compares single-level and multi-level LLIF focusing on sensory and motor disturbances, surgical duration, and quality of life (QOL).</div></div><div><h3>Methods</h3><div>A retrospective review of 139 patients (84 males, 55 females; average age 70 years) with LDD who underwent LLIF and posterior fixation between May 2018 and January 2023 was conducted. Patients were divided into two groups: 89 patients who underwent single-level LLIF and 50 patients who underwent multi-level LLIF (two or more levels). Data on demographics, surgical details, perioperative complications, and clinical outcomes, including pain scores (Numeric Rating Scales: NRS) and QOL assessments (Japanese Orthopaedic Association Back Pain Evaluation Questionnaire: JOABPEQ), were collected preoperatively and one year postoperatively. Statistical analysis was performed to compare the outcomes between the two groups.</div></div><div><h3>Results</h3><div>Patients who underwent multi-level LLIF had significantly longer operative times (145.1 min vs. 98.9 min, <em>p</em> &lt; 0.001) and higher estimated blood loss (126.5 mL vs. 62.9 mL, <em>p</em> &lt; 0.001) compared with the single-level group. Both groups significantly improved pain intensity and QOL, including NRS and JOABPEQ score, with no significant differences in perioperative complication rates (cage subsidence, motor paralysis, thigh pain/numbness) or revision rates (4 % vs. 8 %, <em>p</em> = 0.396).</div></div><div><h3>Conclusions</h3><div>Short-term clinical outcomes suggested that both single-level and multi-level LLIF effectively improved pain and QOL outcomes in patients with LDD.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"134 ","pages":"Article 111082"},"PeriodicalIF":1.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143080208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is time perception Different in focal vs. Generalized Epilepsy? 局灶性癫痫与全身性癫痫的时间感知不同吗?
IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.jocn.2025.111047
Prateek Kumar Panda, Indar Kumar Sharawat
{"title":"Is time perception Different in focal vs. Generalized Epilepsy?","authors":"Prateek Kumar Panda,&nbsp;Indar Kumar Sharawat","doi":"10.1016/j.jocn.2025.111047","DOIUrl":"10.1016/j.jocn.2025.111047","url":null,"abstract":"","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"132 ","pages":"Article 111047"},"PeriodicalIF":1.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142969809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endovascular thrombectomy for large vessel occlusion in acute ischemic stroke patients with concomitant intracranial hemorrhage
IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.jocn.2025.111093
Mohamed Elfil , Lilian Maria Godeiro Coelho , Haneen Sabet , Ahmed Bayoumi , Abdallah Abbas , Tiffany Eatz , Mohammad Aladawi , Zaid Najdawi , Priya Nidamanuri , Sidra Saleem , Lisa Surowiec , Amer Malik

Background

Endovascular thrombectomy (EVT) is the gold standard for acute ischemic stroke (AIS) with large vessel occlusion (LVO). However, concomitant intracranial hemorrhage (ICH) might render AIS-LVO patients ineligible for EVT in real-life practice.

Objective

To provide robust evidence regarding the outcomes of EVT in AIS-LVO patients with concomitant ICH.

Methods

We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and the Cochrane Handbook for Systematic Reviews of Interventions. Data analysis was performed using OpenMetaAnalyst software. We assessed the pooled incidence rate with a 95 % confidence interval (CI) for qualitative data and analyzed the pooled mean difference (MD) with a 95 % CI for continuous data. The pooled effect size for all outcomes was calculated using the DerSimonian and Laird random-effects model.

Results

Six studies were included in the meta-analysis. The overall incidence rate of successful revascularization was 85.3 % (95 % CI: 75.8 %-94.7 %), with rates of 76.1 % for ipsilateral hemorrhages and 66.1 % for contralateral hemorrhages. Functional independence was achieved in 20 % of patients (95 % CI: 4.8 %-36.8 %), with rates of 23 % for ipsilateral and 27.7 % for contralateral hemorrhages. Mortality was reported at 52 % (95 % CI: 34.9 %-69 %), with a higher rate of 52.6 % for ipsilateral hemorrhages compared to 36.8 % for contralateral hemorrhages.

Conclusion

This meta-analysis indicates that EVT is feasible in AIS patients with concurrent ICH, yet it is associated with poor functional outcomes and high mortality rates. Careful patient selection is essential to optimize the outcomes, and further research is needed to enhance outcomes for these high-risk patients.
{"title":"Endovascular thrombectomy for large vessel occlusion in acute ischemic stroke patients with concomitant intracranial hemorrhage","authors":"Mohamed Elfil ,&nbsp;Lilian Maria Godeiro Coelho ,&nbsp;Haneen Sabet ,&nbsp;Ahmed Bayoumi ,&nbsp;Abdallah Abbas ,&nbsp;Tiffany Eatz ,&nbsp;Mohammad Aladawi ,&nbsp;Zaid Najdawi ,&nbsp;Priya Nidamanuri ,&nbsp;Sidra Saleem ,&nbsp;Lisa Surowiec ,&nbsp;Amer Malik","doi":"10.1016/j.jocn.2025.111093","DOIUrl":"10.1016/j.jocn.2025.111093","url":null,"abstract":"<div><h3>Background</h3><div>Endovascular thrombectomy (EVT) is the gold standard for acute ischemic stroke (AIS) with large vessel occlusion (LVO). However, concomitant intracranial hemorrhage (ICH) might render AIS-LVO patients ineligible for EVT in real-life practice.</div></div><div><h3>Objective</h3><div>To provide robust evidence regarding the outcomes of EVT in AIS-LVO patients with concomitant ICH.</div></div><div><h3>Methods</h3><div>We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and the Cochrane Handbook for Systematic Reviews of Interventions. Data analysis was performed using OpenMetaAnalyst software. We assessed the pooled incidence rate with a 95 % confidence interval (CI) for qualitative data and analyzed the pooled mean difference (MD) with a 95 % CI for continuous data. The pooled effect size for all outcomes was calculated using the DerSimonian and Laird random-effects model.</div></div><div><h3>Results</h3><div>Six studies were included in the <em>meta</em>-analysis. The overall incidence rate of successful revascularization was 85.3 % (95 % CI: 75.8 %-94.7 %), with rates of 76.1 % for ipsilateral hemorrhages and 66.1 % for contralateral hemorrhages. Functional independence was achieved in 20 % of patients (95 % CI: 4.8 %-36.8 %), with rates of 23 % for ipsilateral and 27.7 % for contralateral hemorrhages. Mortality was reported at 52 % (95 % CI: 34.9 %-69 %), with a higher rate of 52.6 % for ipsilateral hemorrhages compared to 36.8 % for contralateral hemorrhages.</div></div><div><h3>Conclusion</h3><div>This <em>meta</em>-analysis indicates that EVT is feasible in AIS patients with concurrent ICH, yet it is associated with poor functional outcomes and high mortality rates. Careful patient selection is essential to optimize the outcomes, and further research is needed to enhance outcomes for these high-risk patients.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"134 ","pages":"Article 111093"},"PeriodicalIF":1.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143080206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Statins’ effect on quality of life and functioning in older stroke patients: Systematic review and meta-analysis 他汀类药物对老年脑卒中患者生活质量和功能的影响:系统回顾和荟萃分析。
IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.jocn.2024.110989
Susanna R. Prins , Sarah E. Vermeer , Birgit A. Damoiseaux-Volman , Simone Priester-Vink , Nathalie Van der Velde , Renske M. Van den Berg-Vos

Background

Limited evidence exists on the efficacy and safety of statins in older ischemic stroke or transient ischemic attack patients, particularly in frail individuals. Studies often exclude frail patients, limiting insights on optimal treatments for the entire older population. This review aims to evaluate the effect of statins for secondary prevention on quality of life and functioning in older patients following an ischemic stroke or transient ischemic attack, as these outcomes are aligned with the treatment goals of this patient population.

Methods

We performed a systematic review and meta-analysis by searching four major databases up to June 6th, 2023. Studies were included if they involved statins, assessed quality of life or functioning, focused on older patients, and addressed ischemic stroke or transient ischemic attack.

Findings

We included six randomized controlled trials and 16 cohort studies, totaling 66.273 patients. Mean or median age ranged from 65 to 79 years. Age ranges were not provided, and frailty status was not reported. One trial examined the effect of statins on QoL, yielding mixed results. Regarding the effect of statins on functioning, two trials reported positive effects, two found no effect, and two yielded mixed results. The meta-analysis of cohort studies indicated a positive association between statins and functioning (effect size: 0.43, CI 0.28–0.58). Methodological quality was poor, primarily due to confounding, participant selection and the allocation of patients into intervention groups.

Conclusion

We could not draw definitive conclusions regarding the effect of statins and QoL or functioning in older stroke patients. Mixed results were found in RCTs, and while a positive association between statins and functional outcome was observed in cohort studies, this should be interpreted with caution due to methodological limitations. Future research should focus on age-specific analyses and adequate representation of frail individuals to clarify this issue.
背景:关于他汀类药物对老年缺血性卒中或短暂性缺血性发作患者的有效性和安全性的证据有限,特别是在体弱个体中。研究经常排除体弱患者,限制了对整个老年人群的最佳治疗方法的见解。本综述旨在评估他汀类药物二级预防对缺血性卒中或短暂性缺血性发作后老年患者生活质量和功能的影响,因为这些结果与该患者群体的治疗目标一致。方法:检索截至2023年6月6日的4个主要数据库,进行系统综述和meta分析。如果研究涉及他汀类药物,评估生活质量或功能,关注老年患者,并解决缺血性卒中或短暂性缺血性发作,则纳入研究。结果:我们纳入了6项随机对照试验和16项队列研究,共计66.273例患者。平均或中位年龄为65至79岁。没有提供年龄范围,也没有报告虚弱状况。一项试验检查了他汀类药物对生活质量的影响,结果好坏参半。关于他汀类药物对功能的影响,两项试验报告了积极的影响,两项没有发现影响,两项结果好坏参半。队列研究的荟萃分析显示他汀类药物与功能之间存在正相关(效应值:0.43,CI 0.28-0.58)。方法学质量较差,主要是由于混淆、参与者选择和将患者分配到干预组。结论:他汀类药物对老年脑卒中患者生活质量和功能的影响尚不能得出明确的结论。在随机对照试验中发现了不同的结果,虽然在队列研究中观察到他汀类药物与功能预后之间的正相关,但由于方法学的局限性,这应该谨慎解释。未来的研究应该集中在特定年龄的分析和虚弱个体的充分代表来澄清这个问题。
{"title":"Statins’ effect on quality of life and functioning in older stroke patients: Systematic review and meta-analysis","authors":"Susanna R. Prins ,&nbsp;Sarah E. Vermeer ,&nbsp;Birgit A. Damoiseaux-Volman ,&nbsp;Simone Priester-Vink ,&nbsp;Nathalie Van der Velde ,&nbsp;Renske M. Van den Berg-Vos","doi":"10.1016/j.jocn.2024.110989","DOIUrl":"10.1016/j.jocn.2024.110989","url":null,"abstract":"<div><h3>Background</h3><div>Limited evidence exists on the efficacy and safety of statins in older ischemic stroke or transient ischemic attack patients, particularly in frail individuals. Studies often exclude frail patients, limiting insights on optimal treatments for the entire older population. This review aims to evaluate the effect of statins for secondary prevention on quality of life and functioning in older patients following an ischemic stroke or transient ischemic attack, as these outcomes are aligned with the treatment goals of this patient population.</div></div><div><h3>Methods</h3><div>We performed a systematic review and <em>meta</em>-analysis by searching four major databases up to June 6th, 2023. Studies were included if they involved statins, assessed quality of life or functioning, focused on older patients, and addressed ischemic stroke or transient ischemic attack.</div></div><div><h3>Findings</h3><div>We included six randomized controlled trials and 16 cohort studies, totaling 66.273 patients. Mean or median age ranged from 65 to 79 years. Age ranges were not provided, and frailty status was not reported. One trial examined the effect of statins on QoL, yielding mixed results. Regarding the effect of statins on functioning, two trials reported positive effects, two found no effect, and two yielded mixed results. The <em>meta</em>-analysis of cohort studies indicated a positive association between statins and functioning (effect size: 0.43, CI 0.28–0.58). Methodological quality was poor, primarily due to confounding, participant selection and the allocation of patients into intervention groups.</div></div><div><h3>Conclusion</h3><div>We could not draw definitive conclusions regarding the effect of statins and QoL or functioning in older stroke patients. Mixed results were found in RCTs, and while a positive association between statins and functional outcome was observed in cohort studies, this should be interpreted with caution due to methodological limitations. Future research should focus on age-specific analyses and adequate representation of frail individuals to clarify this issue.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"132 ","pages":"Article 110989"},"PeriodicalIF":1.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142854323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of temporary CSF diversion modality on shunt-dependency following aneurysmal subarachnoid hemorrhage: A nationwide assessment 临时脑脊液分流方式对动脉瘤性蛛网膜下腔出血后分流依赖的影响:一项全国性评估。
IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.jocn.2024.111008
Michelle Lin, Jonathan Dallas, Li Ding, Vincent N. Nguyen, Devin Bageac, Benjamin Hopkins, Frank J. Attenello, William J. Mack

Background

Aneurysmal subarachnoid hemorrhage (aSAH) carries a high economic cost and clinical morbidity in the United States. Beyond prolonged admissions and poor post-injury functional status, there is an additional cost of chronic shunt-dependent hydrocephalus for many aSAH patients. Adjuvant lumbar drain (LD) placement has been hypothesized to promote clearance of subarachnoid blood from the cisternal space, with an ultimate effect of decreasing shunt placement rates. In this nationwide database study, we aim to evaluate outcomes associated with different forms of temporary bedside cerebrospinal fluid (CSF) diversion in the aSAH patient cohort.

Methods

Inpatient admissions were queried from the National Inpatient Sample (NIS; 2016–2020). Inclusion criteria included adult patients presenting with non-traumatic SAH that underwent treatment with either non-elective clip ligation or coil embolization of their underlying aneurysms and received either an external ventricular drain (EVD), lumbar drain (LD), or both (EVD + LD) for temporary CSF diversion during that admission. Outcome variables evaluated included inpatient mortality, bacterial meningitis, length of stay, discharge disposition, and need for shunt placement.

Results

A total of 5505 admissions met inclusion criteria, of which 18.42 % required permanent CSF diversion. The majority of patients received EVD alone (4842, 87.96 %). The remaining patients were split between LD alone (366, 6.65 %) or EVD + LD placement (297, 5.4 %). Patients receiving LD alone tended to be healthier, with lower rates of extreme APR-DRG subclass, Elixhauser Comorbidity Index (ECI), and NIS SAH Severity Score (NIS-SSS). Patients in the EVD + LD cohort had higher rates of shunt placement (OR 1.624, p = 0.0009) and higher rates of bacterial meningitis (OR 8.715, p < 0.0001), even when controlling for APR-DRG illness severity and ECI.

Conclusion

Our study found higher rates of permanent CSF diversion, longer lengths of stay, and higher rates of bacterial meningitis in patients receiving both EVD and LD placement. Due to limitations inherent to nationwide database studies, these results should be interpreted cautiously. Further studies are needed to clarify whether adjuvant temporary CSF diversion with LD placement in the aSAH cohort for intent of minimizing chronic shunt-dependence is efficacious.
背景:动脉瘤性蛛网膜下腔出血(aSAH)在美国具有很高的经济成本和临床发病率。除了住院时间延长和损伤后功能状态差外,许多aSAH患者还需要额外的慢性分流依赖性脑积水费用。辅助腰椎引流管(LD)放置被认为可以促进池腔蛛网膜下腔血液的清除,并最终降低分流管放置率。在这项全国性的数据库研究中,我们旨在评估不同形式的临时床边脑脊液(CSF)转移在aSAH患者队列中的相关结果。方法:对全国住院患者样本(NIS;2016 - 2020)。纳入标准包括非外伤性SAH的成年患者,这些患者在入院期间接受了非选择性夹扎或螺旋栓塞治疗,并接受了外脑室引流(EVD)、腰椎引流(LD)或两者(EVD + LD)进行临时脑脊液分流。评估的结果变量包括住院死亡率、细菌性脑膜炎、住院时间、出院处置和分流器放置的需要。结果:5505例患者符合纳入标准,其中18.42%需要永久性脑脊液分流。以单纯EVD患者为主(4842例,87.96%)。其余患者分为单纯LD组(366例,6.65%)和EVD + LD组(297例,5.4%)。单独接受LD治疗的患者更健康,APR-DRG极端亚类、Elixhauser合并症指数(ECI)和NIS SAH严重程度评分(NIS- sss)的发生率更低。EVD + LD队列患者有更高的分流器放置率(OR 1.624, p = 0.0009)和更高的细菌性脑膜炎发生率(OR 8.715, p)。结论:我们的研究发现EVD和LD同时放置的患者永久性脑脊液分流率更高,住院时间更长,细菌性脑膜炎发生率更高。由于全国性数据库研究固有的局限性,这些结果应谨慎解释。需要进一步的研究来阐明在aSAH队列中,为了减少慢性分流依赖而放置LD的辅助暂时性脑脊液分流是否有效。
{"title":"The effect of temporary CSF diversion modality on shunt-dependency following aneurysmal subarachnoid hemorrhage: A nationwide assessment","authors":"Michelle Lin,&nbsp;Jonathan Dallas,&nbsp;Li Ding,&nbsp;Vincent N. Nguyen,&nbsp;Devin Bageac,&nbsp;Benjamin Hopkins,&nbsp;Frank J. Attenello,&nbsp;William J. Mack","doi":"10.1016/j.jocn.2024.111008","DOIUrl":"10.1016/j.jocn.2024.111008","url":null,"abstract":"<div><h3>Background</h3><div>Aneurysmal subarachnoid hemorrhage (aSAH) carries a high economic cost and clinical morbidity in the United States. Beyond prolonged admissions and poor post-injury functional status, there is an additional cost of chronic shunt-dependent hydrocephalus for many aSAH patients. Adjuvant lumbar drain (LD) placement has been hypothesized to promote clearance of subarachnoid blood from the cisternal space, with an ultimate effect of decreasing shunt placement rates. In this nationwide database study, we aim to evaluate outcomes associated with different forms of temporary bedside cerebrospinal fluid (CSF) diversion in the aSAH patient cohort.</div></div><div><h3>Methods</h3><div>Inpatient admissions were queried from the National Inpatient Sample (NIS; 2016–2020). Inclusion criteria included adult patients presenting with non-traumatic SAH that underwent treatment with either non-elective clip ligation or coil embolization of their underlying aneurysms <em>and</em> received either an external ventricular drain (EVD), lumbar drain (LD), or both (EVD + LD) for temporary CSF diversion during that admission. Outcome variables evaluated included inpatient mortality, bacterial meningitis, length of stay, discharge disposition, and need for shunt placement.</div></div><div><h3>Results</h3><div>A total of 5505 admissions met inclusion criteria, of which 18.42 % required permanent CSF diversion. The majority of patients received EVD alone (4842, 87.96 %). The remaining patients were split between LD alone (366, 6.65 %) or EVD + LD placement (297, 5.4 %). Patients receiving LD alone tended to be healthier, with lower rates of extreme APR-DRG subclass, Elixhauser Comorbidity Index (ECI), and NIS SAH Severity Score (NIS-SSS). Patients in the EVD + LD cohort had higher rates of shunt placement (OR 1.624, p = 0.0009) and higher rates of bacterial meningitis (OR 8.715, p &lt; 0.0001), even when controlling for APR-DRG illness severity and ECI.</div></div><div><h3>Conclusion</h3><div>Our study found higher rates of permanent CSF diversion, longer lengths of stay, and higher rates of bacterial meningitis in patients receiving both EVD and LD placement. Due to limitations inherent to nationwide database studies, these results should be interpreted cautiously. Further studies are needed to clarify whether adjuvant temporary CSF diversion with LD placement in the aSAH cohort for intent of minimizing chronic shunt-dependence is efficacious.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"132 ","pages":"Article 111008"},"PeriodicalIF":1.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142894676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evolving treatment paradigms of cerebral aneurysm stasis in flow diversion 血流转移中脑动脉瘤淤滞治疗模式的演变。
IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.jocn.2024.110996
Joshua H. Weinberg , Max Gruber , Nathan Ritchey, Landon Ehlers, Santino Cua, Amanda Zakeri, Ciaran Powers, Shahid Nimjee, Patrick Youssef

Introduction

Flow diversion is an effective first-line treatment for intracranial aneurysms; however, the rate of incomplete occlusion is not insignificant. Data in neuroendovascular literature is limited regarding the implications of persistent incomplete occlusion despite flow diversion.

Methods

We conducted a retrospective analysis of a prospectively maintained database and identified 125 consecutive patients with treatment naïve intracranial aneurysms who underwent flow diversion with the PED from April 2014 − November 2022. Patients were divided into 3 groups based on the duration of stasis: venous, capillary, and no stasis. Comparative and multivariate analyses were performed between the three groups.

Results

At latest follow-up, complete occlusion occurred in 69.6 % and 82.4 % showed progression of occlusion. Retreatment was required in 2.4 %. There was no significant difference in retreatment (p = 0.667), complete occlusion (p = 0.774) or progression of occlusion (p = 0.848) at latest follow up. No patients experienced subarachnoid hemorrhage post-treatment. On multivariate analysis, hypertension was a negative predictor for complete occlusion (p = 0.006) and progression of occlusion (p = 0.017), while duration of stasis was noncontributory. The mean latest follow up was 12.55 months.

Conclusion

Flow diversion is a safe and effective first line treatment for intracranial aneurysms with a relatively low complication rate. Hypertension was a negative predictor of complete occlusion and progression of occlusion, while the degree of occlusion post-flow diversion may not be predictive of future rupture risk and the Raymond Roy Occlusion classification may not apply. The degree of stasis after initial treatment was not predictive of future occlusion, retreatment, nor aneurysm rupture risk. However, stasis degree may be worth additional analysis given this studies sample size, lack of long-term follow-up, and the lack of predictive factors in current literature to guide post-flow diversion management.
导言:分流是治疗颅内动脉瘤的有效一线治疗方法;然而,不完全闭塞率并非微不足道。尽管血流转移,但神经血管内文献中关于持续不完全闭塞的影响的数据有限。方法:我们对前瞻性维护的数据库进行了回顾性分析,并确定了2014年4月至2022年11月期间125例连续接受PED分流治疗naïve颅内动脉瘤患者。根据瘀血持续时间将患者分为静脉、毛细血管、无瘀血3组。对三组患者进行比较分析和多变量分析。结果:最近一次随访时,69.6%的患者完全咬合,82.4%的患者咬合进展。需要再治疗的占2.4%。最后随访时两组再治疗(p = 0.667)、完全咬合(p = 0.774)和咬合进展(p = 0.848)无显著差异。治疗后无蛛网膜下腔出血。在多变量分析中,高血压是完全闭塞(p = 0.006)和闭塞进展(p = 0.017)的负相关预测因子,而停滞期的持续时间则不是影响因素。平均最新随访时间为12.55个月。结论:分流术是治疗颅内动脉瘤安全有效的一线治疗方法,并发症发生率较低。高血压是完全闭塞和闭塞进展的负预测因子,而血流转移后的闭塞程度可能不能预测未来的破裂风险,雷蒙德罗伊闭塞分类可能不适用。初始治疗后的停滞程度不能预测未来的闭塞、再治疗或动脉瘤破裂的风险。然而,鉴于本研究的样本量,缺乏长期随访,以及目前文献中缺乏指导分流后管理的预测因素,停滞程度可能值得进一步分析。
{"title":"Evolving treatment paradigms of cerebral aneurysm stasis in flow diversion","authors":"Joshua H. Weinberg ,&nbsp;Max Gruber ,&nbsp;Nathan Ritchey,&nbsp;Landon Ehlers,&nbsp;Santino Cua,&nbsp;Amanda Zakeri,&nbsp;Ciaran Powers,&nbsp;Shahid Nimjee,&nbsp;Patrick Youssef","doi":"10.1016/j.jocn.2024.110996","DOIUrl":"10.1016/j.jocn.2024.110996","url":null,"abstract":"<div><h3>Introduction</h3><div>Flow diversion is an effective first-line treatment for intracranial aneurysms; however, the rate of incomplete occlusion is not insignificant. Data in neuroendovascular literature is limited regarding the implications of persistent incomplete occlusion despite flow diversion.</div></div><div><h3>Methods</h3><div>We conducted a retrospective analysis of a prospectively maintained database and identified 125 consecutive patients with treatment naïve intracranial aneurysms who underwent flow diversion with the PED from April 2014 − November 2022. Patients were divided into 3 groups based on the duration of stasis: venous, capillary, and no stasis. Comparative and multivariate analyses were performed between the three groups.</div></div><div><h3>Results</h3><div>At latest follow-up, complete occlusion occurred in 69.6 % and 82.4 % showed progression of occlusion. Retreatment was required in 2.4 %. There was no significant difference in retreatment (<em>p</em> = 0.667), complete occlusion (<em>p</em> = 0.774) or progression of occlusion (<em>p</em> = 0.848) at latest follow up. No patients experienced subarachnoid hemorrhage post-treatment. On multivariate analysis, hypertension was a negative predictor for complete occlusion (p = 0.006) and progression of occlusion (p = 0.017), while duration of stasis was noncontributory. The mean latest follow up was 12.55 months.</div></div><div><h3>Conclusion</h3><div>Flow diversion is a safe and effective first line treatment for intracranial aneurysms with a relatively low complication rate. Hypertension was a negative predictor of complete occlusion and progression of occlusion, while the degree of occlusion post-flow diversion may not be predictive of future rupture risk and the Raymond Roy Occlusion classification may not apply. The degree of stasis after initial treatment was not predictive of future occlusion, retreatment, nor aneurysm rupture risk. However, stasis degree may be worth additional analysis given this studies sample size, lack of long-term follow-up, and the lack of predictive factors in current literature to guide post-flow diversion management.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"132 ","pages":"Article 110996"},"PeriodicalIF":1.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142894719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The “make a flower bud and push at neck” technique: A safe and versatile technique for Woven EndoBridge treatment “制作花蕾并推脖子”技术:编织内桥治疗的安全而通用的技术。
IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.jocn.2024.110942
Jun Tanabe , Ichiro Nakahara , Shoji Matsumoto , Jun Morioka , Tetsuya Hashimoto , Junpei Koge , Kenichiro Suyama , Takeya Suzuki , Akiko Hasebe , Sadayoshi Watanabe

Purpose

The safety and efficacy of Woven EndoBridge (WEB) treatment has been proven. However, only a few standard techniques for safe and versatile WEB deployment have been described in the literature. In this study, we introduce the “make a flower bud and push at neck” technique to achieve safety and versatility during WEB treatment, referred to simply as the “flower bud” technique.

Methods

Consecutive patients who underwent WEB treatment between January 2021 and October 2023 were included. We dichotomized the techniques of WEB deployment into two: the “flower bud” technique and the ordinary unsheath technique. Patient demographics, clinical characteristics of the aneurysms, and treatment results were compared between the two techniques to evaluate the safety and versatility of the “flower bud” technique.

Results

Of 100 aneurysms, 96 were eligible in the study. The “flower bud” technique was applied in 79 aneurysms (82.3 %), and the ordinary unsheath technique was applied in 17 aneurysms (17.7 %). The aneurysm location significantly differed between both techniques. The degree of parent artery-aneurysm (PA) angle and the proportion of the PA angle ≥ 45° were significantly higher in the “flower bud” technique than in the ordinary unsheath technique (P = 0.024 and P = 0.009, respectively). Effective angiographical results and low morbidity/mortality rate were similar in the techniques, although intraoperative rupture was experienced in one aneurysm treated using the ordinary unsheath technique.

Conclusion

The “make a flower bud and push at neck” technique could be safer and more versatile in treating cerebral aneurysms by WEB compared to the ordinary unsheath technique.
目的:证实了Woven EndoBridge (WEB)治疗的安全性和有效性。然而,文献中只描述了一些用于安全和通用WEB部署的标准技术。在这项研究中,我们介绍了“制作花蕾并在颈部推”技术,以实现WEB治疗过程中的安全性和通用性,简称“花蕾”技术。方法:纳入2021年1月至2023年10月期间连续接受WEB治疗的患者。我们将WEB部署技术分为两种:“花蕾”技术和普通的脱鞘技术。比较两种技术的患者人口统计、动脉瘤的临床特征和治疗结果,以评估“花苞”技术的安全性和通用性。结果:100个动脉瘤中,96个符合研究条件。“花苞”技术应用于动脉瘤79例(82.3%),普通无鞘技术应用于动脉瘤17例(17.7%)。动脉瘤的位置在两种技术之间有显著差异。“花苞”技术的载瘤动脉-动脉瘤(PA)夹角程度和PA夹角≥45°的比例均显著高于普通无鞘技术(P = 0.024和P = 0.009)。有效的血管造影结果和低发病率/死亡率在技术上是相似的,尽管在术中使用普通的无鞘技术治疗动脉瘤时经历了一次破裂。结论:“造花芽推颈”技术治疗脑动脉瘤比普通开鞘技术更安全、更通用。
{"title":"The “make a flower bud and push at neck” technique: A safe and versatile technique for Woven EndoBridge treatment","authors":"Jun Tanabe ,&nbsp;Ichiro Nakahara ,&nbsp;Shoji Matsumoto ,&nbsp;Jun Morioka ,&nbsp;Tetsuya Hashimoto ,&nbsp;Junpei Koge ,&nbsp;Kenichiro Suyama ,&nbsp;Takeya Suzuki ,&nbsp;Akiko Hasebe ,&nbsp;Sadayoshi Watanabe","doi":"10.1016/j.jocn.2024.110942","DOIUrl":"10.1016/j.jocn.2024.110942","url":null,"abstract":"<div><h3>Purpose</h3><div>The safety and efficacy of Woven EndoBridge (WEB) treatment has been proven. However, only a few standard techniques for safe and versatile WEB deployment have been described in the literature. In this study, we introduce the “make a flower bud and push at neck” technique to achieve safety and versatility during WEB treatment, referred to simply as the “flower bud” technique.</div></div><div><h3>Methods</h3><div>Consecutive patients who underwent WEB treatment between January 2021 and October 2023 were included. We dichotomized the techniques of WEB deployment into two: the “flower bud” technique and the ordinary unsheath technique. Patient demographics, clinical characteristics of the aneurysms, and treatment results were compared between the two techniques to evaluate the safety and versatility of the “flower bud” technique.</div></div><div><h3>Results</h3><div>Of 100 aneurysms, 96 were eligible in the study. The “flower bud” technique was applied in 79 aneurysms (82.3 %), and the ordinary unsheath technique was applied in 17 aneurysms (17.7 %). The aneurysm location significantly differed between both techniques. The degree of parent artery-aneurysm (PA) angle and the proportion of the PA angle ≥ 45° were significantly higher in the “flower bud” technique than in the ordinary unsheath technique (P = 0.024 and P = 0.009, respectively). Effective angiographical results and low morbidity/mortality rate were similar in the techniques, although intraoperative rupture was experienced in one aneurysm treated using the ordinary unsheath technique.</div></div><div><h3>Conclusion</h3><div>The “make a flower bud and push at neck” technique could be safer and more versatile in treating cerebral aneurysms by WEB compared to the ordinary unsheath technique.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"132 ","pages":"Article 110942"},"PeriodicalIF":1.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142780255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vanishing Rathke’s cleft cyst 消失的 Rathke 裂囊。
IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.jocn.2024.110986
Charles Champeaux Depond , Dahmane Elhairech , Philippe Metellus
{"title":"Vanishing Rathke’s cleft cyst","authors":"Charles Champeaux Depond ,&nbsp;Dahmane Elhairech ,&nbsp;Philippe Metellus","doi":"10.1016/j.jocn.2024.110986","DOIUrl":"10.1016/j.jocn.2024.110986","url":null,"abstract":"","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"132 ","pages":"Article 110986"},"PeriodicalIF":1.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142824268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Benefits and risks of antiplatelet therapy after bypass surgery for moyamoya disease: A meta-analysis 烟雾病搭桥手术后抗血小板治疗的获益和风险:一项荟萃分析
IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.jocn.2024.110956
Junchen Si , Xiaokui Kang , Zhongchen Li, Jiheng Hao, Liyong Zhang

Background

Bypass surgery is a leading treatment strategy for moyamoya disease. Antiplatelet therapy (APT) has the potential to prevent thrombosis and possibly enhance bypass graft patency. However, the efficacy and safety of APT following bypass surgery remain debatable. This study aims to assess the clinical outcomes of APT after bypass surgery.

Methods

A systematic review was conducted to evaluate the impact and associated complications of APT after bypass surgery. Electronic databases, including PubMed, Embase, and the Cochrane Library, were searched from their inception to September 1, 2023. The primary outcome was bypass patency.

Results

This meta-analysis included five articles, encompassing 480 patients who underwent APT post-surgery and 423 patients who did not receive APT. Statistical analysis revealed that APT significantly increased bypass vessel patency (Odds Ratio [OR] 2.58; 95 % Confidence Interval [CI] 1.51–4.43; P = 0.0006), decreased the likelihood of transient cerebral ischemic events (OR 0.55; 95 % CI 0.32–0.95; P = 0.03), and enhanced patient functional outcomes (OR 1.88; 95 % CI 1.29–2.74; P = 0.001). However, no substantial differences were observed in postoperative stroke risk (OR 0.89; 95 % CI 0.49–1.63; P = 0.72), seizures (OR 1.43; 95 % CI 0.61–3.37; P = 0.41), or cerebral hemorrhage (OR 0.69; 95 % CI 0.28–1.71; P = 0.42) between the two groups.

Conclusions

The current evidence indicates that APT after bypass surgery enhances bypass vessel patency, reduces the risk of transient cerebral ischemic events, and improves functional outcomes in patients. However, it does not decrease the incidence of postoperative stroke and does not elevate the risks of cerebral hemorrhage and seizures.
背景:搭桥手术是烟雾病的主要治疗策略。抗血小板治疗(APT)有可能预防血栓形成,并可能提高搭桥通畅。然而,旁路手术后APT的有效性和安全性仍有争议。本研究旨在评估搭桥术后APT的临床效果。方法:系统评价搭桥术后APT的影响及相关并发症。电子数据库,包括PubMed, Embase和Cochrane图书馆,从其成立到2023年9月1日进行了检索。主要结果为旁路通畅。结果:本荟萃分析纳入5篇文章,包括480例术后接受APT治疗的患者和423例未接受APT治疗的患者。统计分析显示,APT可显著增加旁路血管通畅(优势比[OR] 2.58;95%置信区间[CI] 1.51-4.43;P = 0.0006),降低了短暂性脑缺血事件的可能性(OR 0.55;95% ci 0.32-0.95;P = 0.03),增强了患者的功能结局(OR 1.88;95% ci 1.29-2.74;p = 0.001)。然而,术后卒中风险无显著差异(OR 0.89;95% ci 0.49-1.63;P = 0.72),癫痫发作(OR 1.43;95% ci 0.61-3.37;P = 0.41)或脑出血(or 0.69;95% ci 0.28-1.71;P = 0.42)。结论:目前的证据表明,旁路手术后APT可以增强旁路血管的通畅,降低短暂性脑缺血事件的风险,改善患者的功能结局。然而,它不会降低术后中风的发生率,也不会增加脑出血和癫痫发作的风险。
{"title":"Benefits and risks of antiplatelet therapy after bypass surgery for moyamoya disease: A meta-analysis","authors":"Junchen Si ,&nbsp;Xiaokui Kang ,&nbsp;Zhongchen Li,&nbsp;Jiheng Hao,&nbsp;Liyong Zhang","doi":"10.1016/j.jocn.2024.110956","DOIUrl":"10.1016/j.jocn.2024.110956","url":null,"abstract":"<div><h3>Background</h3><div>Bypass surgery is a leading treatment strategy for moyamoya disease. Antiplatelet therapy (APT) has the potential to prevent thrombosis and possibly enhance bypass graft patency. However, the efficacy and safety of APT following bypass surgery remain debatable. This study aims to assess the clinical outcomes of APT after bypass surgery.</div></div><div><h3>Methods</h3><div>A systematic review was conducted to evaluate the impact and associated complications of APT after bypass surgery. Electronic databases, including PubMed, Embase, and the Cochrane Library, were searched from their inception to September 1, 2023. The primary outcome was bypass patency.</div></div><div><h3>Results</h3><div>This <em>meta</em>-analysis included five articles, encompassing 480 patients who underwent APT post-surgery and 423 patients who did not receive APT. Statistical analysis revealed that APT significantly increased bypass vessel patency (Odds Ratio [OR] 2.58; 95 % Confidence Interval [CI] 1.51–4.43; P = 0.0006), decreased the likelihood of transient cerebral ischemic events (OR 0.55; 95 % CI 0.32–0.95; P = 0.03), and enhanced patient functional outcomes (OR 1.88; 95 % CI 1.29–2.74; P = 0.001). However, no substantial differences were observed in postoperative stroke risk (OR 0.89; 95 % CI 0.49–1.63; P = 0.72), seizures (OR 1.43; 95 % CI 0.61–3.37; P = 0.41), or cerebral hemorrhage (OR 0.69; 95 % CI 0.28–1.71; P = 0.42) between the two groups.</div></div><div><h3>Conclusions</h3><div>The current evidence indicates that APT after bypass surgery enhances bypass vessel patency, reduces the risk of transient cerebral ischemic events, and improves functional outcomes in patients. However, it does not decrease the incidence of postoperative stroke and does not elevate the risks of cerebral hemorrhage and seizures.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"132 ","pages":"Article 110956"},"PeriodicalIF":1.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142791764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The doctor-patient perception mismatch: Improving approaches to assessing outcomes after ischemic stroke treated with reperfusion therapy 医患感知不匹配:改进评估缺血性卒中再灌注治疗后预后的方法。
IF 1.9 4区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2025-02-01 DOI: 10.1016/j.jocn.2024.110981
Jane Khalife , Mary Penckofer , Michael J. Dubinski , Danielle C. Brown , Kenyon Sprankle , Taryn Hester , Marta Olive Gadea , Federica Rizzo , Marc Ribo , H.Christian Schumacher , Jesse M. Thon , Tudor G. Jovin , Manisha Koneru , Khalid A. Hanafy
The long-term effects of ischemic stroke on cognition and mental health are not reflected in traditional outcome metrics, like the modified Rankin Scale (mRS) for functional independence. Consequently, this may lead to mismatches in perceptions of overall recovery, despite otherwise qualifying as having good functional outcomes (mRS 0–2). In our multicenter, multinational analysis, we aim to describe the prevalence of, and factors associated with, patient-reported cognitive impairment despite achieving good functional outcomes. Acute ischemic stroke patients at Cooper University Hospital (2021–2024) and Hospital Vall d’Hebron in Barcelona, Spain (2020–2021) treated with reperfusion therapy and achieved 90-day mRS 0–2 were surveyed with the previously-validated PROMIS Global-10 scale for physical health (PROMIS-PH) and mental health (PROMIS-MH). The primary outcome was the rate of fair or poor PROMIS-MH scores ( 11). Univariable and multivariable linear regressions for PROMIS-MH scores were performed. Of 157, 90-day mRS 0–2 patients, the mean age was 68 (standard deviation 15) years, and 61 % were male. Fair or poor PROMIS-MH scores were reported in 43 % of patients. Clinical factors independently associated with PROMIS-MH scores in a multivariable linear regression include: sex, tobacco use, PROMIS-PH score, and National Institutes of Health Stroke Scale at 3-day follow-up. Despite achieving favorable post-stroke mRS, there is a high prevalence of patient-reported cognitive impairment, underscoring an important gap in post-stroke care. The emphasis in post-stroke care should extend beyond the scope of traditional metrics, and should encompass evaluations and interventions targeting additional domains significant to overall patient recovery, especially patient-reported cognitive symptoms.
缺血性卒中对认知和心理健康的长期影响并没有反映在传统的结局指标中,如功能独立性的改良Rankin量表(mRS)。因此,这可能导致对整体恢复的看法不匹配,尽管在其他方面具有良好的功能结果(mRS 0-2)。在我们的多中心、多国分析中,我们的目标是描述患者报告的认知障碍的患病率和相关因素,尽管取得了良好的功能结果。在库珀大学医院(2021-2024)和西班牙巴塞罗那Vall d'Hebron医院(2020-2021)接受再灌注治疗并达到90天mRS 0-2的急性缺血性卒中患者,使用先前验证的PROMIS Global-10身体健康量表(promise - ph)和精神健康量表(promise - mh)进行调查。主要结局是promise - mh评分公平或差的比率(≤11)。对promise - mh评分进行单变量和多变量线性回归。在157例90天mRS 0-2患者中,平均年龄为68岁(标准差15),61%为男性。43%的患者报告了一般或较差的promise - mh评分。在多变量线性回归中,与promise - mh评分独立相关的临床因素包括:性别、吸烟、promise - ph评分和3天随访时的美国国立卫生研究院卒中量表。尽管获得了良好的脑卒中后mRS,但患者报告的认知障碍患病率很高,这强调了脑卒中后护理的重要差距。卒中后护理的重点应超越传统指标的范围,并应包括针对对患者整体康复有重要意义的其他领域的评估和干预措施,特别是患者报告的认知症状。
{"title":"The doctor-patient perception mismatch: Improving approaches to assessing outcomes after ischemic stroke treated with reperfusion therapy","authors":"Jane Khalife ,&nbsp;Mary Penckofer ,&nbsp;Michael J. Dubinski ,&nbsp;Danielle C. Brown ,&nbsp;Kenyon Sprankle ,&nbsp;Taryn Hester ,&nbsp;Marta Olive Gadea ,&nbsp;Federica Rizzo ,&nbsp;Marc Ribo ,&nbsp;H.Christian Schumacher ,&nbsp;Jesse M. Thon ,&nbsp;Tudor G. Jovin ,&nbsp;Manisha Koneru ,&nbsp;Khalid A. Hanafy","doi":"10.1016/j.jocn.2024.110981","DOIUrl":"10.1016/j.jocn.2024.110981","url":null,"abstract":"<div><div>The long-term effects of ischemic stroke on cognition and mental health are not reflected in traditional outcome metrics, like the modified Rankin Scale (mRS) for functional independence. Consequently, this may lead to mismatches in perceptions of overall recovery, despite otherwise qualifying as having good functional outcomes (mRS 0–2). In our multicenter, multinational analysis, we aim to describe the prevalence of, and factors associated with, patient-reported cognitive impairment despite achieving good functional outcomes. Acute ischemic stroke patients at Cooper University Hospital (2021–2024) and Hospital Vall d’Hebron in Barcelona, Spain (2020–2021) treated with reperfusion therapy and achieved 90-day mRS 0–2 were surveyed with the previously-validated PROMIS Global-10 scale for physical health (PROMIS-PH) and mental health (PROMIS-MH). The primary outcome was the rate of fair or poor PROMIS-MH scores (<span><math><mrow><mo>≤</mo></mrow></math></span> 11). Univariable and multivariable linear regressions for PROMIS-MH scores were performed. Of 157, 90-day mRS 0–2 patients, the mean age was 68 (standard deviation 15) years, and 61 % were male. Fair or poor PROMIS-MH scores were reported in 43 % of patients. Clinical factors independently associated with PROMIS-MH scores in a multivariable linear regression include: sex, tobacco use, PROMIS-PH score, and National Institutes of Health Stroke Scale at 3-day follow-up. Despite achieving favorable post-stroke mRS, there is a high prevalence of patient-reported cognitive impairment, underscoring an important gap in post-stroke care. The emphasis in post-stroke care should extend beyond the scope of traditional metrics, and should encompass evaluations and interventions targeting additional domains significant to overall patient recovery, especially patient-reported cognitive symptoms.</div></div>","PeriodicalId":15487,"journal":{"name":"Journal of Clinical Neuroscience","volume":"132 ","pages":"Article 110981"},"PeriodicalIF":1.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142807338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Clinical Neuroscience
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1